355 related articles for article (PubMed ID: 11697063)
1. [Adenovirus vectors and their clinical application in gene therapy].
Adám E; Nász I
Orv Hetil; 2001 Sep; 142(38):2061-70. PubMed ID: 11697063
[TBL] [Abstract][Full Text] [Related]
2. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications.
Romano G; Michell P; Pacilio C; Giordano A
Stem Cells; 2000; 18(1):19-39. PubMed ID: 10661569
[TBL] [Abstract][Full Text] [Related]
3. Progress towards gene therapy for cancer.
Marchisone C; Pfeffer U; Del Grosso F; Noonan DM; Santi L; Albini A
J Exp Clin Cancer Res; 2000 Sep; 19(3):261-70. PubMed ID: 11144517
[TBL] [Abstract][Full Text] [Related]
4. Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors.
Fleury S; Driscoll R; Simeoni E; Dudler J; von Segesser LK; Kappenberger L; Vassalli G
Basic Res Cardiol; 2004 Jul; 99(4):247-56. PubMed ID: 15221342
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral strategies for the gene therapy of cancer.
Relph KL; Harrington KJ; Pandha H
Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial design for adenoviral gene therapy products.
Shirakawa T
Drug News Perspect; 2009 Apr; 22(3):140-5. PubMed ID: 19440556
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer technology in therapy: current applications and future goals.
Romano G; Pacilio C; Giordano A
Stem Cells; 1999; 17(4):191-202. PubMed ID: 10437982
[TBL] [Abstract][Full Text] [Related]
8. Engineered adenovirus serotypes for overcoming anti-vector immunity.
Dharmapuri S; Peruzzi D; Aurisicchio L
Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
[TBL] [Abstract][Full Text] [Related]
9. Somatic gene therapy. Present situation and future perspective.
Gottschalk U; Chan S
Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with adenovirus in cancer therapy.
Palmer DH; Mautner V; Kerr DJ
Curr Opin Mol Ther; 2002 Oct; 4(5):423-34. PubMed ID: 12435043
[TBL] [Abstract][Full Text] [Related]
11. Production of first generation adenovirus vectors: a review.
Danthinne X; Imperiale MJ
Gene Ther; 2000 Oct; 7(20):1707-14. PubMed ID: 11083491
[TBL] [Abstract][Full Text] [Related]
12. Development and application of adenoviral vectors for gene therapy of cancer.
Zhang WW
Cancer Gene Ther; 1999; 6(2):113-38. PubMed ID: 10195879
[TBL] [Abstract][Full Text] [Related]
13. Development of PEGylated adenovirus vector with targeting ligand.
Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
[TBL] [Abstract][Full Text] [Related]
14. Use of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities.
Amalfitano A
Curr Opin Mol Ther; 2003 Aug; 5(4):362-6. PubMed ID: 14513678
[TBL] [Abstract][Full Text] [Related]
15. Gutless adenovirus: last-generation adenovirus for gene therapy.
Alba R; Bosch A; Chillon M
Gene Ther; 2005 Oct; 12 Suppl 1():S18-27. PubMed ID: 16231052
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated transfer of regulable gene expression.
Tsai SY; Schillinger K; Ye X
Curr Opin Mol Ther; 2000 Oct; 2(5):515-23. PubMed ID: 11249754
[TBL] [Abstract][Full Text] [Related]
17. Basics of cancer gene therapy.
Runnebaum IB
Anticancer Res; 1997; 17(4B):2887-90. PubMed ID: 9329555
[TBL] [Abstract][Full Text] [Related]
18. [Gene transfer systems and gene therapy].
Yilmaz E
Mikrobiyol Bul; 2003 Jan; 37(1):89-98. PubMed ID: 12838683
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy of hereditary diseases].
Ginter EK
Vopr Med Khim; 2000; 46(3):265-78. PubMed ID: 11033886
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy: concepts and methods. Few applications so far.
Prescrire Int; 2009 Dec; 18(104):276-9. PubMed ID: 20027718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
